Archive for March, 2011

Shrinks on the couch as they ponder who is and is not crazy

Thursday, March 17th, 2011

Business Day – March 17, 2011

by Marika Sboros

At the heart of this matter is a nasty predilection some psychiatrists have for medicalising normality

Diagnosis is a slippery slope. It involves concepts that are virtually impossible to define precisely with bright lines at the boundaries

SOME psychiatrists — the ones who don’t believe they are godlike creatures — are in a bit of a tizz these days. They are worried about all the damage they might have unwittingly done by misdiagnosing mental illness.

Libyan leader Colonel Muammar Gaddafi could help to ease their furrowed brows.

Some background, before I explain that apparent non-sequitur: In a soul-searching analysis of his profession in Wired magazine recently, US psychiatrist Dr Allen Frances declares that mental disorders “can’t be defined”, and it’s “bull—-” to suggest otherwise.

Frances is lead editor of the DSM-IV, the fourth edition of the American Psychiatric Association’s Diagnostic and Statistical Manual. It’s a publication that has been described as “the bible” and “the imperial doctrine” of psychiatrists.

It’s what shrinks use, in their godlike wisdom, to decide whether or not you are mentally ill — and then to prescribe powerful, dangerous drugs, and other treatments that can turn you into a shadow of your former self.

In the gut-wrenching Wired article, Frances says: “We psychiatrists have made mistakes that had terrible consequences.”

In particular, he believes the manual has inadvertently facilitated the massive increase in recent years of diagnoses of autism, attention deficit disorders and bipolar depression — that used to be called manic depression, because of the manic swings in mood that characterise the condition.

He believes psychiatrists largely bear the responsibility for a massive increase in child bipolar diagnoses, and an epidemic of prescriptions for dangerous, antipsychotic drugs for very young children — below the age of five.

At the heart of this matter is a nasty predilection some psychiatrists have for medicalising normality, or as Wired writer Gary Greenberg says of the DSM, “to chalk up life’s difficulties to mental illness, and then treat them with psychiatric drugs”.

After all, it’s one thing to be thought of as having the blues after a protracted period of difficulty in your life. It’s quite another to be diagnosed as nuts. Mental illness is a serious diagnosis, aggravated by the burden of stigma that weighs down those deemed to have it. It wreaks havoc on lives, families, reputations and careers.

Yet diagnosis is a slippery slope. It involves concepts that “are virtually impossible to define precisely with bright lines at the boundaries”, says Frances.

He has accused colleagues “not just of bad science, but of bad faith, hubris, and blindness, of making diseases out of everyday suffering and, as a result, padding the bottom lines of drug companies”, as Greenberg so eloquently puts it.

Frances has joined forces with Dr Robert Spitzer, editor of the previous edition DSM-III, to prevent the current DSM-V from bulldozing its way down the same damaging path.

That’s a battle they look unlikely to win, given the power of the vested interests involved. And while this may all seem a little in-medical-house, it has implications for the many at the mercy of psychiatrists.

Frances fears the DSM will continue the “wholesale imperial medicalisation of normality”. It may create yet another bonanza for the pharmaceutical industry with a proposed, new “pre-psychotic disorder” — as if the manual doesn’t contain enough disorders from which pharmaceutical companies can make massive profits.

Of course, there’s nothing new about the idea that psychiatry is unscientific. The most famous proponent of that is US psychiatrist Dr Thomas Szaz, professor emeritus of psychiatry at the State University of New York Health Science Centre since 1990.

Szaz put his iconoclastic views forward in his books, The Myth of Mental Illness, published in 1960, and 10 years later in The Manufacture of Madness: A comparative study of the inquisition and the mental health movement.

These are damning critiques from a fine mind on psychiatry’s moral and scientific foundations — and mania for social control.

But what, you might ask, has this to do with Gaddafi?

Well, the Libyan leader is nothing if not a fascinating specimen, psychiatrically speaking, and an argument for the existence of mental illness. After all, if something looks like a duck, acts like a duck, walks like a duck, sounds like a duck, it’s a duck.

Gaddafi looks, acts, sounds and struts around like a madman. He provides a veritable smorgasbord of disorders guaranteed to titillate the mental tastebuds of orthodox psychiatrists, and have them reaching for their prescription pads in a flash.

Gaddafi, according to DSM specifications, could be diagnosed with borderline personality disorder — psychobabble psychiatrists have dreamt up to pigeonhole people who don’t or won’t do as others expect them to do.

He’s more likely to be diagnosed with into-the-abyss megalomania, paranoia, psychopathy, with a hint of schizophrenia.

Szaz might argue that Gaddafi’s madness is manufactured, a product of the toxic environment he created over the 42 years of his rule, wallowing in the absolute power that corrupts body and mind absolutely.

His bloated, puffy, sallow complexion suggests bad diet, and other unhealthy lifestyle habits that may contribute to the misfiring of neurons in his grey matter. Yet I doubt even the humane and holistic treatment methods Szaz advocates could bring Gaddafi back from the mad brink to anything resembling rational, normal, decent behaviour.

Marika Sboros is Health News editor.

http://www.businessday.co.za/articles/Content.aspx?id=137544

« Return to news items


Share

In Ireland: No Consent for 12% of those getting electroshocked

Wednesday, March 16th, 2011

Note from CCHR:  Electroshock is the “treatment” psychiatrists employ when their first line of “treatment”— drugs—fail to work.  And the drugs inevitably fail to work,  simply because they are no more effective than placebo, yet have side effects rivaling the most hardcore street drugs.    In the U.S. alone, more than 100,000 people are electroshocked every year, and the majority of them are elderly.   But psychiatrists also electroshock two of the other most vulnerable subjects; pregnant women and children.  Hard to believe, but true.   And what’s more,  psychiatrists are pushing harder than ever for increases in electroshock treatment, recently lobbying the U.S. FDA to downgrade electroshock machines from the most high risk category of device (Class III) to Class II.   They failed.  And the reason they failed is because the facts were made known by CCHR and other experts who testified before the FDA.  You can read about this FDA hearing here: http://www.cchrint.org/2011/01/31/fda-advisory-panel-recommends-electroshock-device-too-risky-for-reclassification/

The article below talks about the administration of electroshock without the consent of the patient.  But even in cases where the patient does give consent, do we really believe they or their family members are getting enough information to make an informed choice?  Are they told psychiatrists still have no idea how electroshock “works?”  That if they imagine sticking their finger in a light socket, then multiply that current by about 3-4 times, they will have an idea of the amount of electricity that will be sent searing through the brain?  Are they told they could lose their memories, often permanently? Not remember their own wedding or where they were born, or their own children?  That side effects also include death? Or how about the fact that electroshock treatment was born in Italy, 1938,  when psychiatrist Ugo Cerletti saw pigs being made more docile before slaughter so decided to give it a shot on humans?   Are those facts in the consent form?

To get the facts about Electroshock, watch this video:
Electroshock: It’s Not Treatment, It’s Torture
http://www.youtube.com/cchrint#p/c/5/QDR3cD8_kck



The Irish Independent, March 16, 2011

By Eilish O’Regan

Almost one in eight patients who were given electric shock treatment over the course of a year were either unable or unwilling to give consent to the controversial procedure.

A higher number of women (62.5pc) than men were given the electroconsvulsive treatment (ECT) without consent, the 2009 monitoring report from the Mental Health Commission watchdog revealed.

The majority of the 373 treatments were given to patients who gave their agreement — but the law does allow for it to be given in cases where a person is “unwilling or unable to do so”.

However, where ECT is given without the permission of the patient, the treating doctor has to ensure he or she gets a second opinion from another psychiatrist who must agree it is the best course. They do not need to get the consent of family members.

The report, which looked at 66 mental health centres, found that there were 34 fewer programmes of ECT administered in 2009 compared to 2008.

St Patrick’s Hospital in Dublin, the largest of the centres, had the highest number of ECT treatments (126) and accounted for one third of all cases.

St Brigid’s Hospital in Ballinasloe had the second highest number followed by the Department of Psychiatry in Waterford Regional Hospital.

The patients were mostly suffering from depression while others had schizophrenia and mania.

The main reason for resorting to electric shock treatment was the patient’s lack of response to medication.

Other reasons included risk of suicide and physical deterioration and where a “rapid response” was deemed necessary in a significant number of the patients.

An improvement was seen in the vast majority of patients but no improvement was seen in 5.4pc of those treated. It was stopped in a small number of cases due to complications.

Irish psychiatrists have differing views on the merits of the treatment with some saying it should be stopped because of complications such as risk of memory loss.

Seizure

If ECT is recommended, the patient is given a general anaesthetic and medication to relax their muscles. Electrodes are then placed on the person’s head and a pulse of electricity passed through the brain which will set off a fit or seizure.

The patient normally has around six to 12 sessions with two administered a week. Electricity changes the chemical composition of the patient’s brain and lifts them out of their low mood.

‘Coronation Street’ actress Beverly Callard credits ECT with rescuing her from severe depression after she was unresponsive to medication.

The College of Psychiatry in Ireland has proposed changes in selecting a doctor asked for a second opinion. The doctor should be part of a panel set up by the Mental Health Commission and would also have to consult with others treating the patient.

http://www.independent.ie/health/latest-news/no-consent-for-12pc-of-electric-shock-care-2581131.html

« Return to news items


Share

Profiting from mental ill-health

Tuesday, March 15th, 2011

There’s a reason psychiatrists prescribe drugs rather than talking therapy: the latter makes no money for pharmaceutical firms

The Guardian
By Harriet Fraad
March 15, 2011

More than one in ten Americans takes Prozac; the US comprises 5% of the world's population, yet consumes two thirds of psychological medications. Photograph: Stone/Jonathan Nourok/Getty

The New York Times recently led with a front-page splash about psychiatry’s propensity to prescribe pills, “Talk Doesn’t Pay, So Psychiatry Turns Instead to Drug Therapy”. That news is already widely known in the mental health field, but it has vast ramifications for Americans trying to maintain their sanity in our market-driven and medical system for delivering mental healthcare.

What does the turn to drug therapy mean for the mass of Americans?

Mental illness has not decreased with the change from talk therapy to drugs. In fact, as Robert Whitaker’s book diagnoses, mental illness in America has become an established epidemic. So-called miracle drugs like Prozac are taken by 11% of the population – and Prozac is only one of the 30 available antidepressants on the market. Antidepressants are accompanied by anti-anxiety and anti-psychotic drugs. Xanax, America’s leading anti-anxiety medication, is so ubiquitous that Xanax generates more revenue than Tide detergent, reports Charles Barber in his Comfortably Numb.

Anti-psychotics drugs alone net the pharmaceutical industry at least $14.6bn dollars a year. Psycho-pharmaceuticals are the most profitable sector of the industry, which makes it one of the most profitable business sectors in the world. Americans are less than 5% of the world’s population, yet they consume 66% of the world’s psychological medications.

Do these psycho pharmaceuticals work to restore mental health? Actually, the evidence is overwhelming that they fail. Antidepressants, the most popular psycho-pharmaceuticals, work no better than placebos. They work 25% of the time and stop working when the user stops taking them. In addition, they may actually harm patients in the long run. They disrupt brain neurotransmitters and may usurp the brain’s organic soothing functions.

Psycho-pharmaceuticals are less effective in the long run than talk therapy. Talk therapy, like drugs, does change brain and body chemistry; unlike drugs, though, talk therapy has no side-effects. Instead, talk therapy gives a patient tools that usually help to solve future problems. The latest research is most clearly expressed in both Irving Kirsch’s Antidepressants: The Emperors New Drugs and Gary Greenberg’s, Manufacturing Depression, both published last year. Kirsch is one of the world’s leading psychiatrists; Greenberg is one of the world’s most prestigious psychologists. Their views are echoed by many voices in the field of mental health. Why is prestigious and extensive research so widely ignored by doctors and patients alike? Our market-driven healthcare system gives us clues.

All 30 of the available antidepressants have suffered lawsuits within five years of their appearance on the market. These suits are often settled with large payments and gag clauses. The new generation of anti-psychotics are the latest case in point. Anti-psychotics were the single biggest targets of the False Claims Act. Every major company selling anti-psychotics – Bristol Meyers Squibb, Eli Lilly, Pfizer, Johnson and Johnson and AstraZeneca – has either settled investigations for healthcare fraud or is currently being investigated for it. Two recent settlements involving charges of illegal marketing set records for the largest criminal fines ever imposed on corporations. Their corporate logic is expressed in the words of Dr Jerome Avorn, a medical professor and researcher at Harvard: “When you are selling a billion a year or more of a drug, it’s very tempting for a company to just ignore the traffic ticket and keep speeding.”

There is also the widespread practice of paying physicians and psychiatrists heavy subsidies to recommend psycho-pharmaceuticals to their colleagues in small meetings at which a drug company representative is present. If doubt or criticism of the discussed drug is expressed, the doctor’s stipend stops. Another legally acceptable tool is to publish praise of a company’s drug in a scholarly article, which is often written by drug company personnel and simply tweaked by the physician whose name appears on the article. The physician is paid handsomely for such a service.

Under the pressure of legal settlements and embarrassing disclosures, eight pharmaceutical companies began posting doctors’ names and compensation on the web. ProPublica compiled these disclosures, totaling $320m, into a single database that allows patients to search for their doctor. Receiving payments for publishing articles written by drug companies is not illegal.

Two doctors, Dr Joseph Biederman and Dr Timothy Wilens of Harvard University Medical School, illustrate the close and cozy relationship between medical “scholarship” and drug companies. Drs Biederman and Wilens netted $1.6m each from drug companies for their work in recommending powerful anti-psychotic drugs for children. Biederman, Wilens and other extremely well-rewarded child psychiatrists are in part responsible for giving children the diagnosis of paediatric bipolar disorder for which anti-psychotic drugs like Risperidal and Zyprexa are used.

Experts agree that there is no long-term improvement in children’s lives from taking anti-psychotic drugs. In fact, these drugs have a substantiated pattern of metabolic problems and rapid weight gain that often leads to diabetes. The use of bipolar diagnoses and bipolar medications is one small example of how market-driven mental healthcare works in the United States. It illustrates the transformation of US healthcare into a system dominated by some of the richest corporations in the world.

Caring about profit is first, and that is why psychiatry has turned to drug therapy.

Read article here:  http://www.guardian.co.uk/commentisfree/cifamerica/2011/mar/15/psychology-healthcare

« Return to news items


Share

Dr. Peter Breggin, psychiatrist—”Join the Empathic Transformation”

Tuesday, March 15th, 2011

Note from CCHR:  What many may not realize about our organization is that it is called the Citizens  Commission on Human Rights  (CCHR) because we have hundreds of Commissioners (advisors) including educators, medical doctors, attorney’s, psychologists and yes, even psychiatrists that work alongside CCHR—In fact, our co-founder was psychiatrist Thomas Szasz.    And while we don’t all hold the same opinions on everything to do with mental health, what we do hold in common is our goal to eradicate psychiatric abuse and restore human rights to the field of mental health.    There are also a number of psychiatrists and psychologists who work independent of CCHR,  but whose efforts to reform the field of mental health are strongly supported by CCHR.    This is the case with Dr. Peter Breggin.  He is not a Commissioner, and works independently of CCHR, but we fully support his efforts towards creating a mental health system based on empathy, compassion, non-drug and non-harmful solutions, eradicating bogus mental disorder diagnoses,  and above all,  respect for the individual’s  human rights.   Now that,  is something we can all agree upon.

The Huffington Post, March 15, 2011

by Dr. Peter Breggin

Peter R. Breggin, MD is a psychiatrist in private practice in Ithaca, New York, and the author of dozens of scientific articles and more than twenty books

It’s part biological and part psychological and spiritual. But there’s no doubt about the direction that humankind must go in–toward empathic individual relationships and ultimately a more empathic culture. Until human beings truly learn to love and to understand one another, and to adopt empathic attitudes and practices, the world will remain mired in misery and conflict. Until those of us in the healing arts come to this realization we will often do more harm than good, and never fulfill our potential to give and to heal.

Utopia is a long way off. Social utopia is probably beyond human capacity. But in our individual lives, families and communities, we can act from empathy–from a genuine treasuring of each other, and a belief that human nature and the human spirit everywhere in the world long for freedom and more loving community.

Yes, there is evil in the universe; some individuals and some ideologies promote hatred and destruction. At times aggressors will require us to defend ourselves. But our basic thrust must always remain toward spreading empathy.

Every human being is born with a powerful empathic impulse. Except under the direst circumstances, it begins to flower in the first few years of life. Even toddlers feel concern for other toddlers and will seek to comfort each other. Empathy is so inherent in human nature, I have seen it flourish in some of the most abused children I have known in my work as a psychiatrist.

Consider why we have these large frontal lobes that fill the anterior portion of our skulls. They weren’t developed to build technology or even to create art–there was little or none of that at the time 100,000 years ago when we reached our current biological state. Our frontal lobes developed as a part of our becoming sensitive social human beings capable of caring, cooperation and communicating verbally with each other.

Whether you believe in Darwinian evolution, Intelligent Design, or a combination of both, these frontal lobes of ours give us the biological capacity to express the highest ethical, psychological and spiritual ideals, including our yearning for life, liberty and the pursuit of happiness in a responsible fashion. Psychiatric drugs suppress that biological capacity, putting a chemical barrier into place that divides us from ourselves and from others. Psychiatric diagnoses which justify these drugs further the alienation from our real selves and from others.

As the recent New York Times story confirms, most psychiatrists don’t even do psychotherapy anymore; they simply diagnose and drug. As I first described in Toxic Psychiatry, medically-oriented mental health professionals have become remote from their patients whom they now seek to manipulate chemically rather than to know personally.

In the field we call mental health, the rampant diagnosing, drugging, and incarcerating of those we seek to help must be replaced by practices that encourage responsibility and freedom rather than compliance and docility. By working directly in the field of ethical human services and sciences, we can become a leading part in the grassroots movement we call the Empathic Transformation.

All over the world, those of us who practice the healing arts–physical, psychological and spiritual–are seeing the need to join together to further humanity’s empathic transformation–to transform the old ways into something better and even grander, into practices embedded in and imbued with empathy.

The world is changing and we need to lead the movement in our fields toward a view of human beings that never demeans and always empowers, that never forces but always encourages, and that recognizes that human beings are not ultimately driven by their instincts and their biochemical but by their ideals and principles.

You do not have to be a professional to join the Empathic Transformation movement. The Empathic Transformation is larger than any one profession; empathy is not the province of professionals alone. Empathy encompasses everything we humans do with each other. That’s why we call our new nonprofit organization The Center for the Study of Empathic Therapy, Education and Living. Especially in the field of mental health and personal growth the real hope for the future lies beyond those of us who are professionals.

There are not enough professionals to address the whole of human emotional and spiritual suffering, and professionals often become too boxed in by their ideology and too self-serving to provide the best solutions. Peer counseling, Twelve Step programs, religious and spiritual alternatives, and a broad array of non-medical retreats and approaches must be encouraged and eventually must flourish. The great numbers of people who desire nontoxic, empathic alternatives must demand them and help to create them.

People are coming from all over the world to our Empathic Therapy Conference in Syracuse, New York, April 8-10. Join them and join us. If you are interested in learning more about empathic human services and empathic living, this conference will provide you information and inspiration. You can find everything you need to know, including how to sign up, at www.empathictherapy.org.

Peter R. Breggin, MD is a psychiatrist in private practice in Ithaca, New York, and the author of dozens of scientific articles and more than twenty books including Toxic Psychiatry: Why Therapy, Empathy and Love Must Replace the Drugs, Electroshock and Biochemical Theories of the “New” Psychiatry, as well as his newest book, Medication Madness. The Empathic Therapy Conference brings together more than forty presenters and a diverse audience from around the world. Professionals and nonprofessionals are welcome. Learn about the conference at http://www.empathictherapy.org.

http://www.huffingtonpost.com/dr-peter-breggin/join-the-empathic-transfo_b_834706.html

« Return to news items


Share

Oh That? Seroquel Marketing Undeterred by This Week’s Deceptive Marketing Settlement

Tuesday, March 15th, 2011

OpEdNews  March 15, 2011

by Martha Rosenberg

Google the word “depression” and the first search result you’ll get is for the antipsychotic Seroquel XR.

Visit WebMD and the home page hosts similar ads for Seroquel XR, above and adjacent to the lead news story.

Who would know AstraZeneca inked the largest multi-state consumer protection settlement on record relating to deceptive Seroquel marketing just this week? For $68.5 million? Only a year after inking a similar settlement related to burying side effect and safety information for $520 million with the government?

Who would know AstraZeneca has already settled nearly 25,000 personal injury lawsuits pertaining to Seroquel with more to come says ABC news?

First approved in 1997, Seroquel has enjoyed the camel-nose-under-the-tent phenomenon known as indications creep. First approved for schizophrenia, it was later approved for bipolar disorder and psychiatric conditions in children. But it was Seroquel’s 2009 approval as an add-drug for depression that helped it reach its spectacular sales of $5.3 billion in 2010 thanks to the US’ walloping depression “market” of 20 million.

Seroquel’s blood sugar, weight gain and heart side effects are well known. That’s why FDA regulators opposed its use as a first choice, stand-alone treatment for the 10 percent of the US population with depression when safer drugs exist. “I saw no clear advantage demonstrated in efficacy,” said Dr. Wayne Goodman who chaired the FDA panel considering the depression indication. “There were side effects, and I would expect unintended consequences associated with wide-scale use of the drug.”

The drug also can cause increased mortality in elderly patients with dementia-related psychosis, suicidality, neuroleptic malignant syndrome, cataracts, seizures, increases in blood pressure and movement disorders in neonates when their mothers take it.

Seroquel’s fraud trail is also well known with more than six conflict of interest scandals swirling around Seroquel researchers and promoters. Psychiatrist Richard Borison was sentenced to a 15-year prison sentence in 1998 for a pay-to-play Seroquel research scheme which helped establish Seroquel’s original perception as safe.

But how many realize Seroquel’s cost to the individual taxpayer and health insurance consumers at a Red Book price of almost $500 per month per person?

Auditors with the Michigan Corrections Department say the state could save $350,000 a month by switching just half of its Seroquel prescriptions to another pill. (Anyone know a school that could use $350,000 a month?) And North Carolina spends $29.4 million per year on Seroquel prescriptions. Who knows how much else states and taxpayers are paying to control the metabolic side effects that emerge with Seroquel?

Reports are also starting to surface about the effect $6,000-a-year Seroquel prescriptions, many unnecessary and inappropriate, are having on rising insurance premiums themselves for private insurance holders.

In fact, the public is really paying twice for the irrepressible Seroquel marketing. First for drug purchases in state and private plans (and the advertising) and second in side effects from a drug whose safety continues to be in doubt.

http://www.opednews.com/articles/Oh-That-Seroquel-Marketin-by-Martha-Rosenberg-110315-836.html

« Return to news items


Share

Mental health patients complain of ‘zombification’

Tuesday, March 15th, 2011

Note from CCHR:  The article posted below is about involuntary commitment under the U.K.’s  use of “community treatment orders” under their Mental Health Act.   Since these involuntary commitment orders have gone into effect (2008), the number of people forced into psychiatric wards has 10xed what was expected.   Quite simply,  if you are diagnosed mentally ill, you can lose all your civil and human rights.  Even if you commit no crime, you can be incarcerated in a psychiatric facility against your will.   The idea of “danger to self or others” is also a very, very loose description and particularly horrifying in the UK, considering they also have laws against what they term “anti-social behavior.”   From the New American:

In July 1998, the U.K.’s Crime and Disorder Act enacted the “Anti-Social Behaviour Orders” (ASBOs) to tackle disagreeable and disruptive acts. ASBOs are court-ordered restrictions on “unsociable conduct.” Breaching an ASBO is a criminal offense.

Eight years into the legislation, some 12,675 ASBOs had been issued. Nearly 2,000 youngsters, aged 10 to 17, were jailed by 2007 for an average of six months each for breaching ASBOs [the rest were all adults]. Even that was not enough. According to Mail Online, May 27, 2007 (“Revealed: Blair’s secret stalker squad”), the government attempted to widen the definition of “mental disorder” so that the right not to be detained in a psychiatric facility based on cultural, political, or religious beliefs would be forfeited.

So, what are some of the offenses that would constitute getting as ASBO?   Try spitting in the street, swearing, “noise pollution” being drunk, loitering, intimidation…think we’re kidding? Read this http://en.wikipedia.org/wiki/Anti-Social_Behaviour_Order

The “community treatment orders” under UK’s Mental Health Act are considered “psychiatric ASBOs.” http://www.independent.co.uk/life-style/health-and-families/health-news/psychiatric-asbos-will-fail-say-mental-health-experts-438809.html So, if you are diagnosed “mentally ill” you can be ordered to act a certain way, take your drugs, be forced to have  a curfew, not be allowed to consume alcohol.  Now think about that for a minute;  Millions of citizens have been diagnosed with one or more mental disorders, be it “bipolar, “depressed” or “ADHD” to name but a few.  Once labeled “mentally ill” – game over.  You can be court ordered to behave a certain way or face psychiatric incarceration.  Plain and simple. This is the Brave New World of Psychiatry. See links and references at the end of this post read this article from the and more links at the end of this post

Excessive use of forced detention and coerced treatment by the NHS means patients have little control over their treatment

The Guardian
By Mark Gould
March 15, 2011

Between 2008-09 and 2009-10 there was a 17.5% increase in the number of people being sectioned under the Mental Health Act. Photograph: Alamy

“I became ‘zombified’ for nearly 12 months when I was forced to take mood stabilisers and antipsychotic medication,” says Reka Krieg. The 30-year-old has bipolar disorder, so has periods of manic activity and psychotic episodes, which led to her being forcibly detained and treated in hospital in 2009.

Krieg’s case exemplifies the crisis in NHS psychiatric care, which is resulting in excessive use of coercive detention and treatment of people with mental illness. Latest statistics released in January show a 17.5% rise in the number of people being “sectioned” – under the Mental Health Act (MHA) – from 32,649 in 2008‑09 to 38,369 in 2009-10. This means that nearly 40% of patients in NHS psychiatric units are there under legal duress.

Years of drastic bed cuts mean wards are full of only the most unwell patients – those seen to be a danger to themselves or others. This includes rising numbers coming into hospital via the judicial system. Eight hundred and thirty women detained under the MHA came into hospital via prison or the courts last year, a rise of more than 85%, while the number of men rose by 48%, from 1,982 to 2,935.

The use of community treatment orders (CTOs) has also rocketed. Since they were introduced in 2008, more than 6,200 have been served – 10 times the expected number. Under a CTO, patients are released from detention, but can be forcibly returned to hospital if they fail to take their medication or other treatment. However, patients complain that once given a CTO, it takes them too long to get it removed, obliging them to stick with medication they believe they no longer need.

CTOs are “a complete waste of money,” says Krieg. “I had a history of repeat hospital admission, but I was better when they decided to impose the CTO, which I hated. I felt I had no control over my human rights.” She was finally released from the CTO after two appeals with the help of a specialist lawyer.

And it seems that CTOs have not eased the pressure on psychiatric wards. Last November, the Care Quality Commission, which oversees patients detained under the MHA, found that some hospitals were reporting 125% bed occupancy rates, and nearly a third of the 486 locked NHS wards in England and Wales had occupancy rates of 100% or more, meaning they were forced to send patients home early to accommodate new arrivals.

Mental health charities and senior psychiatrists say the situation is appalling, and they are lobbying for changes to the health and social care bill currently going through parliament, to make it harder to impose compulsory treatment.

Tony Zigmond, the Royal College of Psychiatrists’ lead on mental health law, says the situation is “a disgrace”. He fears some mental health services are becoming so focused on the risk of patients harming themselves or others that they make excessive use of compulsion and coercion.

He describes detention under mental health law as “a lobster pot – easy to get into but hard to get out”. His college and the Mental Health Alliance, an umbrella group of charities, civil liberties organisations and lawyers, are lobbying MPs to amend the health and social care bill to make it harder to impose CTOs. Otherwise, he fears the use of CTOs could spiral out of control. “The top line is that CTOs have increased the number of detentions,” he says. “In effect, they are prisons without walls so the numbers on them could be limitless.”

Paul Farmer, chief executive of mental health charity Mind, says he is “extremely worried” about the rise in CTOs, “especially as 30% of them are being imposed on people who have no history of not co-operating with treatment”. He adds: “CTOs are a looming threat of readmission hanging over the heads of people who are trying to rebuild their lives and independence.”

Lee Milner, 41, has schizoaffective disorder, which results in episodes of elation or depression coupled with hallucinations. A volunteer and campaigner with mental health charity Rethink, Lee has had extensive experience of detention in hospital since 1992 when, following the suicide of his father, he tried to set fire to the family home. He was last sectioned in 2010 and agrees that hospitals are packed with only the most serious cases. “The ward was like being in the dark ages. How the nurses qualified I never know … When I tried to talk to the consultant about spirituality, he just asked if I wanted more medication.”

Zigmond wants a more consensual approach to treatment, and more space set aside in hospitals for patients to use as sanctuaries in times of crisis. “Why not give patients the option of coming off medication and being able to come into hospital if they need to?” he says.

Read the rest of the article here:  http://www.guardian.co.uk/society/2011/mar/15/mental-health-patients-forced-detention

More on ASBOs

‘Psychiatric asbos’ slammed – UK Health Service Journal

http://www.hsj.co.uk/news/psychiatric-asbos-slammed/36479.article

Psychiatry’s Brave New WorldThe New American

http://thenewamerican.com/index.php/usnews/health-care/4112-psychiatrys-brave-new-world

Asbo capital condemned for ‘abuse of power’

http://www.guardian.co.uk/society/2007/jul/04/localgovernment.publicservicesawards

ASBO WATCH

http://www.statewatch.org/asbo/ASBOwatch.html

« Return to news items


Share

AG Fines Firm For Improper Marketing Of Seroquel

Monday, March 14th, 2011

North County Gazette-  March 14, 2011

NEW YORK—-The state Attorney General’s office has reached a $3.1 million settlement with the major pharmaceutical company AstraZeneca following allegations that it improperly marketed and promoted the antipsychotic drug Seroquel.

*The agreement is part of a record 37-state settlement totaling $68.5 million – the largest ever multi-state consumer protection-based pharmaceutical settlement.

These practices violate consumer protection laws established to protect patients and ensure that health care providers are fully briefed on the medications available, including all known potential benefits and side effects.

It had been alleged that AstraZeneca engaged in deceptive and misleading practices when it marketed Seroquel for unauthorized, or “off-label,” uses and failed to adequately disclose the drug’s serious potential side effects to health care providers, including hyperglycemia and diabetes mellitus.

Seroquel is approved for the treatment of schizophrenia, certain instances of bipolar disorder and depressive episodes associated with bipolar disorder. When it was first introduced to the market in the 1990s, experts thought that it would be less likely to produce Parkinson’s type symptoms and motion disorders such as tardive dyskinesia, and therefore could be used in long-term treatment of schizophrenia.  However, while Seroquel may reduce the risk of these symptoms, it also produced dangerous side effects, including hyperglycemia and diabetes.

New York’s investigation demonstrated that AstraZeneca concealed and minimized the risks of these side effects.  AstraZeneca also marketed Seroquel for off-label and potentially dangerous uses including pediatric use, for use at high dosage levels, for the treatment of symptoms rather than diagnosed conditions, and to treat dementia and Alzheimer’s Disease in the elderly.

Following the Attorneys General’s investigation, AstraZeneca agreed to change its marketing of Seroquel and to cease promoting off-label uses of the drug, which are not approved by the U.S. Food and Drug Administration (FDA).

The settlement, filed in state court, also contains powerful injunctive terms prohibiting the use of financial incentives to manipulate doctors, deterring off-label marketing and requiring that AstraZeneca disclose scientific evidence of dangerous side effects.

In addition, the settlement requires AstraZeneca to provide accurate, objective and scientifically balanced responses to requests for off-label usage information. AstraZeneca must also have policies in place to ensure that financial incentives are not given to marketing and sales personnel for off-label marketing and that sales personnel do not promote to health care providers who are unlikely to prescribe Seroquel for an FDA-approved use.

http://www.northcountrygazette.org/2011/03/14/seroquel_marketing/

*In addition to New York, attorneys general of the following states and the District of Columbia participated in the settlement: Arizona, California, Colorado, Connecticut, Delaware, Florida, Hawaii, Idaho, Illinois, Iowa, Kansas, Louisiana, Maryland, Maine, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Jersey,  North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Vermont, Washington, West Virginia and Wisconsin.

« Return to news items


Share

Study: Diet May Help ADHD Kids More Than Drugs (yeah, ya think???)

Monday, March 14th, 2011

Note from CCHR:  We added the “yeah, ya think?” to the title because of the word “may” in the headline.   Children are being prescribed Ritalin and Ritalin-like drugs which are categorized as schedule ll by the U.S.  Drug Enforcement Administration as “highly addictive” in the same class as cocaine, opium and morphine.  The US FDA warns  ADHD drugs cause hallucinations, stroke, heart attack and sudden death to name a few (watch Drugging Our Children: Side Effects http://3.ly/atyH.)   Studies also prove that ADHD drugs do not improve children’s academic performance, they simply make the kid sit still and “behave.”   So which is better, diet or drugs? Is there really any question?  Given the fact that ADHD is not a disease, and the fact ADHD drugs are deadly,  we think the the may help kids more than drugs is a bit ridiculous.   Not to mention the fact that just because a kid acts like a kid, (ADHD ‘criteria,’ also known as childhood) they do not deserve to be labeled with a mental disorder and stigmatized mentally ill for the rest of their life.

NPR March 12, 2011

Hyperactivity. Fidgeting. Inattention. Impulsivity. If your child has one or more of these qualities on a regular basis, you may be told that he or she has attention deficit hyperactivity disorder. If so, they’d be among about 10 percent of children in the United States.

Kids with ADHD can be restless and difficult to handle. Many of them are treated with drugs, but a new study says food may be the key. Published in The Lancet journal, the study suggests that with a very restrictive diet, kids with ADHD could experience a significant reduction in symptoms.

The study’s lead author, Dr. Lidy Pelsser of the ADHD Research Centre in the Netherlands, writes in The Lancet that the disorder is triggered in many cases by external factors — and those can be treated through changes to one’s environment.

“ADHD, it’s just a couple of symptoms — it’s not a disease,” the Dutch researcher tells All Things Considered weekend host Guy Raz.

The way we think about — and treat — these behaviors is wrong, Pelsser says. “There is a paradigm shift needed. If a child is diagnosed ADHD, we should say, ‘OK, we have got those symptoms, now let’s start looking for a cause.’ ”

Pelsser compares ADHD to eczema. “The skin is affected, but a lot of people get eczema because of a latex allergy or because they are eating a pineapple or strawberries.”

According to Pelsser, 64 percent of children diagnosed with ADHD are actually experiencing a hypersensitivity to food. Researchers determined that by starting kids on a very elaborate diet, then restricting it over a few weeks’ time.

“It’s only five weeks,” Pelsser says. “If it is the diet, then we start to find out which foods are causing the problems.”

Teachers and doctors who worked with children in the study reported marked changes in behavior. “In fact, they were flabbergasted,” Pelsser says.

“After the diet, they were just normal children with normal behavior,” she says. No longer were they easily distracted or forgetful, and the temper tantrums subsided.

Some teachers said they never thought it would work, Pelsser says. “It was so strange,” she says, “that a diet would change the behavior of a child as thoroughly as they saw it. It was a miracle, a teacher said.”

But diet is not the solution for all children with ADHD, Pelsser cautions.

“In all children, we should start with diet research,” she says. If a child’s behavior doesn’t change, then drugs may still be necessary. “But now we are giving them all drugs, and I think that’s a huge mistake,” she says.

http://www.npr.org/2011/03/12/134456594/study-diet-may-help-adhd-kids-more-than-drugs?sc=emaf

For more information on psychiatric labeling of kids, watch Psychiatry: Labeling Kids with Bogus Mental Disorders http://www.cchrint.org/videos/

For more information on documented side effects of drugs, watch Drugging Our Children – Side Effects :http://www.cchrint.org/videos/drugs/drugging-our-children-side-effects/

« Return to news items


Share

Chemicals Widespread in Minnesota Streams—Most common were Antibiotics, Antidepressants, ADHD Drugs

Friday, March 11th, 2011

ALBERT LEA, MN—A new study shows that potentially harmful chemicals and pharmaceuticals are widespread in Minnesota streams.

The state’s pollution control agency says this can be deadly and mutating to many fish and types of wildlife.

The substances scientists most often found included antibiotics, antidepressants, and drugs for ADHD.

The environmental community says this is a big wake-up call to something that’s being going on for many years.

Randy Tuchtenhagen with Freeborn County Environmental Services says, “Now we’re finding out that things that get flushed down the toilet or poured down the sink are ending up in our waste treatment plants. Waste treatment plants are designed to treat human waste, they aren’t designed to treat pharmaceuticals and chemicals.”

Tuchtenhagen also notes that if a person takes a pill that their body doesn’t fully process, that’s something that ends up in sewage treament plants too and eventually into our streams.

http://www.kimt.com/content/localnews/story/Chemicals-Widespread-in-Minnesota-Streams/d-ERt2LJ7kyujYeg-QMYNg.cspx

« Return to news items


Share

AstraZeneca paying $68.5M to settle off-label marketing charges for anti-psychotic Seroquel

Thursday, March 10th, 2011

ABCNews.com

by Matthew Perrone AP Health Wire, March 10,  2011

Thursday's deal is the second multimillion-dollar Seroquel settlement brought by government prosecutors in the past two years. Last April AstraZeneca agreed to pay $520 million to settle similar allegations brought by the federal Department of Justice.

AstraZeneca will pay $68.5 million as part of a multistate settlement over allegations that the drug developer promoted its blockbuster psychiatric drug Seroquel for insomnia, Alzheimer’s and other unapproved uses.

The New Jersey Attorney General’s Office announced the agreement Thursday, describing it as the largest multistate pharmaceutical settlement of its kind. New Jersey will receive $1.85 million from the deal with 36 other states and the District of Columbia as party to the settlement.

The states alleged that salespeople for AstraZeneca promoted its anti-psychotic Seroquel for off-label, or unapproved uses, and did not disclose side effects of the pill, which include weight gain and muscle spasms.

“Consumers rightfully expect pharmaceutical companies to engage in responsible marketing efforts that are consistent with approved purposes,” said Thomas Calcagni, acting director of New Jersey’s division of consumer affairs.

Seroquel is approved to treat schizophrenia, bipolar disorder and depression, though the majority prescriptions are for off-label uses like insomnia. The drug, approved in 1997, is AstraZeneca’s second-best-selling product, with U.S. sales of $5.3 billion last year. But that success has been marred by frequent allegations that the company illegally marketed the drug and downplayed its risks.

Seroquel’s side effects, including blood sugar increases, weight gain and uncontrollable muscle spasms, have resulted in thousands of lawsuits from patients. The drugmaker had settled nearly 25,000 personal injury lawsuits related to Seroquel at the end of 2010, with 3,950 remaining.

Pharmaceutical companies are prohibited from marketing drugs for unapproved uses, though doctors are free to prescribe them as they choose.

London-based AstraZeneca denied any wrongdoing.

“While we deny the allegations, AstraZeneca believes it is important to bring these matters to a close and move forward with our business of providing medicines to patients,” said company spokesman Tony Jewell, in a statement.

Thursday’s deal is the second multimillion-dollar Seroquel settlement brought by government prosecutors in the past two years. Last April AstraZeneca agreed to pay $520 million to settle similar allegations brought by the federal Department of Justice.

The new settlement stemmed from a separate three-year investigation led by the Attorney General of New Jersey. As part of the agreement AstraZeneca must publish any gifts or payments to physicians on a public website. The company also agreed to make sure that payment incentives to sales representatives do not encourage off-label promotion.

Allegations of off-label drug marketing have become increasingly common in the past decade, with the drug industry eclipsing all others as the source of fraud-related settlements with the federal government. Approximately 80 percent of the $3.1 billion in penalties collected last fiscal year by the government came from the health care sector, including drugmakers, insurers and hospitals, according to Taxpayers Against Fraud.

http://abcnews.go.com/Business/wireStory?id=13105486

« Return to news items


Share